Latest Financial Health News

Lucapa Diamond Company and its subsidiaries have appointed voluntary administrators as they embark on a dual-track recapitalisation and sale process to address financial distress.

Bendigo and Adelaide Bank reported a slight dip in its Common Equity Tier 1 ratio to 10.83% for the March 2025 quarter, reflecting dividend payments and increased residential lending. Despite this, the bank sustained robust liquidity and funding metrics well above regulatory minimums.

SKS Technologies has delivered a robust first half in 2025, showcasing strong revenue growth and a burgeoning project pipeline, underpinned by zero debt and strategic expansion in data centres and traditional electrical services.

RPM Automotive Group has launched a fully operational tyre recycling plant, boosting its earnings potential while reporting steady revenue and improved profitability for the nine months FYTD.

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.

Mayne Pharma has firmly rejected Cosette Pharmaceuticals’ assertion of a Material Adverse Change that could derail their acquisition scheme, insisting the deal process continues as planned.

Catapult Group International Ltd reported a 16.5% increase in revenue to $116.5 million for FY25, driven by strong subscription growth and improved operational efficiency. The company narrowed its net loss after tax to $8.8 million, signaling progress in its global sports technology strategy.

James Hardie has released its financial results for the fourth quarter and full year ended March 31, 2025, accompanied by a suite of detailed reports filed with both the ASX and SEC.

Janus Electric Holdings Limited will have its trading suspension lifted and resume quotation on the ASX from 21 May 2025 after meeting key listing requirements.

Monash IVF Group has lowered its full-year profit guidance for FY2025 to $27.5 million, citing weaker market conditions and ongoing impacts from a recent operational incident in Brisbane. The company remains cautious as it monitors patient trends and legal costs.

Mount Burgess Mining NL has had its trading suspension lifted following a court ruling validating a recent cleansing notice, allowing shares to re-enter the market from 20 May 2025.

OFX Group Limited has requested a trading halt following significant price and volume spikes in its securities, ahead of its scheduled full year results announcement for FY25.